Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Description

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Conditions

Lung Carcinoma

Study Overview

Study Details

Study overview

This clinical trial evaluates the effectiveness of a conversation tool on patient-centered health and decision-making outcomes in patients with lung cancer making treatment decisions. This research is being conducted to help doctors understand the information patients need to participate in shared decision-making about their lung cancer treatment options. The focus of this research is to study how patients choose lung cancer treatment options and the information needed to make that choice, with a focus on patients with lower health literacy.

Improving Decision-Making Encounters in Lung Cancer (I DECide) II: A Randomized Control Trial Of A Low-Literacy Conversation Tool

Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool

Condition
Lung Carcinoma
Intervention / Treatment

-

Contacts and Locations

Hillsboro

Hillsboro Medical Center, Hillsboro, Oregon, United States, 97123

Portland

Adventist Health Portland, Portland, Oregon, United States, 97216

Portland

OHSU Knight Cancer Institute, Portland, Oregon, United States, 97239

Portland

Portland VA Medical Center, Portland, Oregon, United States, 97239

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * AIM 1: Suspected lung cancer
  • * AIM 1: English fluency
  • * AIM 1: \> 6-month life expectancy
  • * AIM 1: Score of ≥ 3 on the cognitive impairment screener
  • * AIM 2 PARTICIPANTS: Participation in Aim 1
  • * AIM 2 CLINICIANS: Discussing lung cancer treatment decisions with Aim 1 participants

Ages Eligible for Study

18 Years to 99 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

OHSU Knight Cancer Institute,

Donald R Sullivan, MD, MA, MCR, PRINCIPAL_INVESTIGATOR, OHSU Knight Cancer Institute

Study Record Dates

2027-12-31